Oxycodone hydrochloride immediate-release analgesic for managing severe pain: abuse-deterrent formulations

This paper is an expert opinion in response to the development of abuse-deterrent immediate-release tablets containing oxycodone HCl. There is a potential impact, both positive and negative, of this type of dosage form on patients, those suffering from the disease of addiction, health care providers...

Full description

Saved in:

Bibliographic Details
Published in:	Therapeutics and clinical risk management Vol. 14; pp. 779 - 782
Main Authors:	Kibbe, A H, Franko, T S, Shah, V M
Format:	Journal Article
Language:	English
Published:	New Zealand Dove Medical Press Limited 01-01-2018 Taylor & Francis Ltd Dove Medical Press
Subjects:	Analgesics Cardiovascular diseases Central nervous system depressants Chronic pain Disease control Drug abuse Drug dosages Drug overdose Expert Opinion FDA approval Health care costs Heart diseases IV abuse Labeling Medical economics Narcotics Nasal abuse non-metabolizable polymer Opioids Oxycodone Pain Pain management Pharmaceuticals Pharmacy Polymer industry Polymers Prescription drugs Prescription writing Product introduction risk/benefit Stroke Trends United States > US nasal abuse non-metabolizable polymer risk/benefit IV abuse opioids
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	This paper is an expert opinion in response to the development of abuse-deterrent immediate-release tablets containing oxycodone HCl. There is a potential impact, both positive and negative, of this type of dosage form on patients, those suffering from the disease of addiction, health care providers, and the cost of health care.
Bibliography:	SourceType-Other Sources-1 content type line 63 ObjectType-Editorial-2 ObjectType-Commentary-1
ISSN:	1176-6336 1178-203X 1178-203X
DOI:	10.2147/TCRM.S144564